| abstract |
The present invention provides compounds of formula I and II and salts thereof: A-B-C-D-E-F-G-J(I), C-D-E-F-G-J(II), wherein A , B, C, D, E, F, G and J have any of the values defined in this specification. The compounds are useful for inhibiting plasma kallikrein, and for treating diseases or conditions in animals wherein inhibition of plasma kallikrein is indicated. |